SciBase Oncology

An Open Access, Peer Review and International Journal

SciBase Oncology

About the Journal

Oncology has been one of the most prominent fields in the history of medical science and has been growing consistently. Oncology is a branch of medicine which deals with the diagnosis, treatment, and prevention of cancer. It has been evolving with the updates with the new research and discoveries being made regularly. SciBase Oncology is a journal which is reviewed by peers and offers you original and latest information in the field of Oncology.

This journal covers a huge range of topics, which include biology of cancer, clinical oncology practices, cancer prevention and screening protocol, cancer genetics, and newer therapeutic approaches for treatment. It works as a perfect platform for researchers, oncologists, and other medical professionals.

Our journal is aimed at maintaining a high degree of editorial standards. The published content in this journal has a very high quality. Each of the manuscripts submitted here goes through a complete peer-to-peer review. The journal welcomes contributions from experts in the realm of a diverse range of scientific and medical fields.

The journal is committed to providing a platform for scientific excellence wherein it offers the researchers a forum for the proper and practical dissemination of knowledge and information in their research findings. SciBase Oncology is designed to provide you with a complete knowledge of the advancements in oncology. The journal also focuses on the new age technologies, which include genomics and artificial Intelligence, which have been playing a major role in Oncology.

SciBase Oncology serves as an indispensable source for the information on Oncology. This will help you in disseminating the cutting-edge research, opinions, and best practices in oncology.


Contact editorial office at: oncology@scibasejournals.org

Latest Articles

Short Commentary

Revisiting and Re-Considering Containment Discarded Reads from High-Throughput Approaches Aids Host-Microbiota Link in Various Diseases

Mudasir Rashid*

Numerous microbial communities reside in the human body, and it is feasible to consider the microbiota that resides in our gastrointestinal tract and other anatomical locations as a component of the environment to which we are continuously exposed at high doses throughout our lifespan [1-5].

Research Article

Lineage-Specific Mixed Chimerism in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Saadiya Khan; Ibrahim Jafaari; Khawar Siddiqui*; Hawazen AlSaedi; Ali Al-Ahmari; Abdullah Al-Jefri; Ibrahim Ghemlas; Awatif AlAnazi; Mouhab Ayas

Hematopoietic Stem Cell Transplantation (HSCT) is considered a curative option for children with Acute Myeloid Leukemia (AML). Post-HSCT relapse in pediatric AML is associated with poor outcomes. Our ability to predict this event is limited. Chimerism analysis can be followed sequentially to detect Mixed Chimerism (MC) trends to identify the risk of relapse.

Research Article

The Effects of Curcumin on ERĪ±, p53, and p21 in the MCF-7 Breast Cancer Cell Line

Samantha Pfiffner; Aisha Zanib; Nina Prudhomme; Kaylin Whittaker; Raquel Yaldo; Jehan Koujane; Isabella Iskender; Adele Salan; Sumi Dinda*

Curcumin, a golden-yellow flavonoid derived from turmeric, has been used in traditional Chinese and Indian medicine for centuries due to its antioxidant and anti-inflammatory properties. Recent interest has grown in its potential therapeutic applications in cancer research.

Review Article

Glioblastoma and its Microenvironment

Siddharth Shah*

Glioblastoma is the most common and aggressive primary brain tumor in adults. It is characterized by its highly invasive nature and resistance to current treatment strategies. The microenvironment of glioblastoma plays a crucial role in tumor progression and therapeutic resistance.

Research Article

Toxicity Evaluation of 9-Thioansamitocin P3

Natalya I Vasilevich*; Chai Peng Fei; Huangyu Jiang; Haihua Xiao; Kunxian Feng; Chengfang Jian; Min Li1; Alexander V Chestkov; Lichun Sun

In our efforts to extend the possible application of highly cytotoxic maytansine derivatives as a payload in drug delivery systems, we found that thiol group in 9-thioansamitocib P3 could be successfully used to create a disulfide linker to the carrier.

View All Latest Articles

We always publish latest, authentic and relibale information on the website.